These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 23029457)
1. The transcriptional targets of mutant FOXL2 in granulosa cell tumours. Rosario R; Araki H; Print CG; Shelling AN PLoS One; 2012; 7(9):e46270. PubMed ID: 23029457 [TBL] [Abstract][Full Text] [Related]
2. Aromatase is a direct target of FOXL2: C134W in granulosa cell tumors via a single highly conserved binding site in the ovarian specific promoter. Fleming NI; Knower KC; Lazarus KA; Fuller PJ; Simpson ER; Clyne CD PLoS One; 2010 Dec; 5(12):e14389. PubMed ID: 21188138 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of wild-type but not C134W mutant FOXL2 enhances GnRH-induced cell apoptosis by increasing GnRH receptor expression in human granulosa cell tumors. Cheng JC; Klausen C; Leung PC PLoS One; 2013; 8(1):e55099. PubMed ID: 23372819 [TBL] [Abstract][Full Text] [Related]
4. The role of FOXL2 in the pathogenesis of adult ovarian granulosa cell tumours. Rosario R; Cohen PA; Shelling AN Gynecol Oncol; 2014 May; 133(2):382-7. PubMed ID: 24342437 [TBL] [Abstract][Full Text] [Related]
5. Comparative study of microRNA regulation on FOXL2 between adult-type and juvenile-type granulosa cell tumours in vitro. Rosario R; Blenkiron C; Shelling AN Gynecol Oncol; 2013 Apr; 129(1):209-15. PubMed ID: 23280087 [TBL] [Abstract][Full Text] [Related]
6. Mutation of FOXL2 in granulosa-cell tumors of the ovary. Shah SP; Köbel M; Senz J; Morin RD; Clarke BA; Wiegand KC; Leung G; Zayed A; Mehl E; Kalloger SE; Sun M; Giuliany R; Yorida E; Jones S; Varhol R; Swenerton KD; Miller D; Clement PB; Crane C; Madore J; Provencher D; Leung P; DeFazio A; Khattra J; Turashvili G; Zhao Y; Zeng T; Glover JN; Vanderhyden B; Zhao C; Parkinson CA; Jimenez-Linan M; Bowtell DD; Mes-Masson AM; Brenton JD; Aparicio SA; Boyd N; Hirst M; Gilks CB; Marra M; Huntsman DG N Engl J Med; 2009 Jun; 360(26):2719-29. PubMed ID: 19516027 [TBL] [Abstract][Full Text] [Related]
7. The FOXL2 C134W mutation is characteristic of adult granulosa cell tumors of the ovary. Jamieson S; Butzow R; Andersson N; Alexiadis M; Unkila-Kallio L; Heikinheimo M; Fuller PJ; Anttonen M Mod Pathol; 2010 Nov; 23(11):1477-85. PubMed ID: 20693978 [TBL] [Abstract][Full Text] [Related]
8. Functional exploration of the adult ovarian granulosa cell tumor-associated somatic FOXL2 mutation p.Cys134Trp (c.402C>G). Benayoun BA; Caburet S; Dipietromaria A; Georges A; D'Haene B; Pandaranayaka PJ; L'Hôte D; Todeschini AL; Krishnaswamy S; Fellous M; De Baere E; Veitia RA PLoS One; 2010 Jan; 5(1):e8789. PubMed ID: 20098707 [TBL] [Abstract][Full Text] [Related]
9. FOXL2, GATA4, and SMAD3 co-operatively modulate gene expression, cell viability and apoptosis in ovarian granulosa cell tumor cells. Anttonen M; Pihlajoki M; Andersson N; Georges A; L'hôte D; Vattulainen S; Färkkilä A; Unkila-Kallio L; Veitia RA; Heikinheimo M PLoS One; 2014; 9(1):e85545. PubMed ID: 24416423 [TBL] [Abstract][Full Text] [Related]
10. Adult granulosa cell tumours (GCT): clinicopathological outcomes including FOXL2 mutational status and expression. Rosario R; Wilson M; Cheng WT; Payne K; Cohen PA; Fong P; Shelling AN Gynecol Oncol; 2013 Nov; 131(2):325-9. PubMed ID: 24007948 [TBL] [Abstract][Full Text] [Related]
11. Nuclear receptor profiling of ovarian granulosa cell tumors. Alexiadis M; Eriksson N; Jamieson S; Davis M; Drummond AE; Chu S; Clyne CD; Muscat GE; Fuller PJ Horm Cancer; 2011 Jun; 2(3):157-69. PubMed ID: 21761343 [TBL] [Abstract][Full Text] [Related]
12. Differential apoptotic activities of wild-type FOXL2 and the adult-type granulosa cell tumor-associated mutant FOXL2 (C134W). Kim JH; Yoon S; Park M; Park HO; Ko JJ; Lee K; Bae J Oncogene; 2011 Apr; 30(14):1653-63. PubMed ID: 21119601 [TBL] [Abstract][Full Text] [Related]
13. Mouse forkhead L2 maintains repression of FSH-dependent genes in the granulosa cell. Kuo FT; Fan K; Bentsi-Barnes I; Barlow GM; Pisarska MD Reproduction; 2012 Oct; 144(4):485-94. PubMed ID: 22847492 [TBL] [Abstract][Full Text] [Related]
14. FOXO1 mitigates the SMAD3/FOXL2 Secchi C; Benaglio P; Mulas F; Belli M; Stupack D; Shimasaki S J Transl Med; 2021 Feb; 19(1):90. PubMed ID: 33639972 [TBL] [Abstract][Full Text] [Related]
16. Absence of a FOXL2 mutation (402C→G) in the blood of adult-type granulosa cell tumor patients possessing the FOXL2 mutation. Lee S; Kim TH; Won M; Ko JJ; Rho J; Lee K; Bae J Int J Gynecol Cancer; 2010 Nov; 20(8):1341-3. PubMed ID: 21051974 [TBL] [Abstract][Full Text] [Related]
17. A current perspective on the pathological assessment of FOXL2 in adult-type granulosa cell tumours of the ovary. Kommoss S; Gilks CB; Penzel R; Herpel E; Mackenzie R; Huntsman D; Schirmacher P; Anglesio M; Schmidt D; Kommoss F Histopathology; 2014 Feb; 64(3):380-8. PubMed ID: 24192202 [TBL] [Abstract][Full Text] [Related]
18. Mutational analysis of FOXL2 codon 134 in granulosa cell tumour of ovary and other human cancers. Kim MS; Hur SY; Yoo NJ; Lee SH J Pathol; 2010 Jun; 221(2):147-52. PubMed ID: 20198651 [TBL] [Abstract][Full Text] [Related]
19. Impact of FOXL2 mutations on signaling in ovarian granulosa cell tumors. Leung DTH; Fuller PJ; Chu S Int J Biochem Cell Biol; 2016 Mar; 72():51-54. PubMed ID: 26791928 [TBL] [Abstract][Full Text] [Related]
20. The FOXL2 mutation (c.402C>G) in adult-type ovarian granulosa cell tumors of three Japanese patients: clinical report and review of the literature. Takahashi A; Kimura F; Yamanaka A; Takebayashi A; Kita N; Takahashi K; Murakami T Tohoku J Exp Med; 2013 Dec; 231(4):243-50. PubMed ID: 24257635 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]